FrancophonIA/ELRC3.0 huggingface dataset:
English: The pharmacokinetic results are presented in the table below, as compared to data for intravenous administration of IG 10% obtained in the same study.
Croatian: Tablica u nastavku prikazuje farmakokinetičke rezultate u usporedbi s podacima o intravenskoj primjeni IG-a 10% dobivenima u istom ispitivanju.
English: • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.
Croatian: • kod hipogamaglobulinemije i ponavljajućih bakterijskih infekcija u bolesnika s kroničnom limfocitnom leukemijom (KLL) u kojih profilaksa antibioticima nije uspjela ili je kontraindicirana,
English: • Colour: o The recombinant human hyaluronidase should be clear and colourless.
Croatian: • Boja: ο Rekombinantna ljudska hijaluronidaza mora biti bistra i bezbojna.
English: Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections
Croatian: kalcijev klorid natrijev hidroksid (za podešavanje pH) kloridna kiselina (za podešavanje pH) voda za injekcije
English: Sodium chloride, sodium phosphate, human albumin, ethylenediaminetetraacetic acid disodium, calcium chloride, water for injections.
Croatian: Natrijev klorid, natrijev fosfat, ljudski albumin, dinatrijeva sol etilendiamintetraoctene kiseline, kalcijev klorid, voda za injekcije.
English: These antibodies bind to red blood cells (RBC) epitops (which may be detected as a positive direct antiglobulin test [DAT, (Coombs' test)] and, rarely, may cause haemolysis.
Croatian: Ta protutijela mogu se vezati na epitope eritrocita (što se može otkriti kao pozitivan direktan antiglobulinski test [DAT, (Coombsov test)]) i, rjeđe, mogu uzorkovati hemolizu.
English: 1 vial human normal immunoglobulin 2.5 g/25 ml
Croatian: 1 bočica normalnog ljudskog imunoglobulina 2,5 g/25 ml
English: Certain adverse reactions may occur more frequently in patients who receive human normal immunoglobulin for the first time or, in rare cases, when the human normal immunoglobulin product is switched or when there has been a long interval since the previous infusion.
Croatian: Neke se nuspojave javljaju češće kod bolesnika koji prvi puta primaju ljudski normalni imunoglobulin ili, rijetko, kod prijelaza s jednog na drugi normalni ljudski imunoglobulin ili kad je prošlo dugo razdoblje od prethodne infuzije.
English: HyQvia may reduce the effect of some virus vaccines such as measles, rubella, mumps and chicken pox (live virus vaccines).
Croatian: HyQvia može smanjiti djelotvornost nekih virusnih cjepiva kao što su ospice, rubeola, zaušnjaci i varičela (živa virusna cjepiva).
English: Arterial and venous thromboembolic events including myocardial infarction, stroke, deep venous thrombosis and pulmonary embolism have been associated with the use of immunoglobulins.
Croatian: Arterijski i venski tromboembolijski događaji, uključujući infarkt miokarda, moždani udar, duboku vensku trombozu i plućnu emboliju povezani su s primjenom imunoglobulina.
English: The effects of antibodies that bind to recombinant human hyaluronidase on human fertility are unknown.
Croatian: Učinci protutijela koja se vežu na rekombinantnu ljudsku hijaluronidazu na ljudsku plodnost nisu poznati.
English: Oedema has been reported most frequently in association with large volume subcutaneous fluid administration.
Croatian: Edem je najčešće prijavljivan kod supkutane primjene velikih količina tekućine.
English: • Remove the peel-off label from HyQvia vial, which has the product lot number and expiration date, and place the label in your treatment record/log book.
Croatian: • Odvojite naljepnicu s bočice lijeka HyQvia, na kojoj je naveden broj serije proizvoda i rok trajanja, i stavite naljepnicu u Vaš dnevnik terapije.
English: • If instructed by your health care professional, clean the infusion site(s) with an alcohol swab.
Croatian: • Ako Vas je tako uputio zdravstveni radnik, očistite mjesto/a infuzije tupferom natopljenim alkoholom.
English: Gravitational oedema/genital swelling was observed subsequent to lower abdominal quadrants administration.
Croatian: b Gravitacijski edem/oticanje genitalija primijećeno nakon primjene u niže abdominalne kvadrante.
English: This will be increased step-wise to larger doses at 3- to 4-week intervals with the next infusions.
Croatian: To će se postupno povećavati sa sljedećim infuzijama, pa ćete dobivati veće doze u razmacima od 3 do 4 tjedna.
English: The measures taken for the manufacture of HyQvia are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus and for the non-enveloped hepatitis A virus and parvovirus B19.
Croatian: Poduzete mjere u proizvodnji lijeka HyQvia smatraju se učinkovitima za viruse s ovojnicom kao što su virus humane imunodeficijencije (HIV), virus hepatitisa B i virus hepatitisa C te za viruse bez ovojnice kao što su virus hepatitisa A i parvovirus B19.
English: Human normal immunoglobulin vial: Glycine, water for injections.
Croatian: Bočica normalnog ljudskog imunoglobulina: glicin, voda za injekcije.
English: One ml of the solution in this vial contains 100 mg of human normal immunoglobulin, of which at least 98% is immunoglobulin G (IgG).
Croatian: Jedan ml ove bočice sadrži 100 mg normalnog ljudskog imunoglobulina, od kojeg je najmanje 98% imunoglobulina G (IgG).
English: • patients with a specific cancer of the bone marrow (multiple myeloma) and lack of antibody production with recurrent infections who have failed to respond to a vaccine against certain bacteria (pneumococci).
Croatian: • bolesnici sa specifičnim rakom koštane srži (multiplim mijelomom) i nedostatkom stvaranja protutijela s ponavljajućim infekcijama koje nisu uspješno reagirale na cjepivo protiv određenih bakterija (pneumokoka)
English: • Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.
Croatian: • kod hipogamaglobulinemije i ponavljajućih bakterijskih infekcija u bolesnika oboljelih od multiplog mijeloma (MM),
English: • Remove the smaller sterile syringe from package and attach to a non-vented spike or needle (device).
Croatian: • Izvadite manju sterilnu štrcaljku iz pakiranja i priključite je na neventilirani šiljasti priključak ili iglu (naprava).
English: Despite these measures, when medicines prepared from human blood or plasma are used, the possibility of passing on infection cannot be totally excluded.
Croatian: Unatoč svim tim mjerama, pri korištenju lijekova pripravljenih od ljudske krvi ili plazme ne može se posve isključiti mogućnost prenošenja infekcije.
English: 1 vial recombinant human hyaluronidase 1.25 ml
Croatian: 1 bočica rekombinantne ljudske hijaluronidaze 1,25 ml
English: • patients with a certain kind of blood cancer (chronic lymphocytic leukaemia) which leads to a lack of antibody production and recurrent infections when preventative antibiotics have failed.
Croatian: • bolesnici s određenom vrstom raka krvi (kronična limfocitna leukemija) koja dovodi do nedostatka stvaranja protutijela i ponavljajućih infekcija kada je izostalo uspješno djelovanje preventivnih antibiotika
English: Following subcutaneous administration of HyQvia, peak serum IgG levels are achieved in the recipient's circulation after approximately 3 to 5 days.
Croatian: Nakon supkutane primjene lijeka HyQvia najviše koncentracije IgG-a u serumu dostignute su u cirkulaciji primatelja nakon približno 3 do 5 dana.
English: HyQvia has to be infused under the skin (subcutaneous or SC administration).
Croatian: Infuzija lijeka HyQvia mora se dati pod kožu (supkutana ili s.c. primjena).
English: Common (≥1/100 to <1/10)
Croatian: Često (≥1/100 i <1/10)
English: • Follow up with physician as directed.
Croatian: • Javite se liječniku za kontrolu prema uputama.
English: Insert the needle:
Croatian: Uvedite iglu:
English: Caution should be exercised in patients with pre-existing risk factors for thromboembolic events (such as advanced age, hypertension, diabetes mellitus and a history of vascular disease or thrombotic episodes, patients with acquired or inherited thrombophilic disorders, patients with prolonged periods of immobilization, severely hypovolemic patients, patients with diseases which increase blood viscosity).
Croatian: Potreban je oprez u bolesnika s unaprijed postojećim faktorima rizika za nastanak tromboembolijskih događaja (poput visoke dobi, hipertenzije, dijabetesa melitusa i anamneze vaskularnih bolesti ili trombotskih događaja, zatim bolesnici sa stečenim ili naslijeđenim sklonostima zgrušavanju krvi, bolesnici koji su tijekom duljeg razdoblja bili imobilizirani, bolesnici s teškom hipovolemijom, kao i bolesnici koji boluju od bolesti koje dovode do povišene viskoznosti krvi).
English: • Pull back on the plunger, fill the smaller syringe with air equal to the amount of recombinant human hyaluronidase in the HY vial(s).
Croatian: • Povucite prema natrag klip, napunite manju štrcaljku zrakom u istoj količini koliko je i rekombinantne ljudske hijaluronidaze u bočici (bočicama) HY.
English: Patients should be reminded to report any chronic inflammation, nodules or inflammation that occurs at the infusion site and lasts more than a few days.
Croatian: Bolesnike treba podsjetiti da prijave kronične upale, čvoriće ili upale nastale na mjestima primjene infuzije, koje traju dulje od nekoliko dana.
English: This should be taken into consideration in patients on a controlled sodium diet.
Croatian: O tome treba voditi računa u bolesnika na dijeti s kontroliranim (niskim) unosom natrija.
English: The active substance of HyQvia is human normal immunoglobulin.
Croatian: Djelatna tvar lijeka HyQvia je normalni ljudski imunoglobulin.
English: • Visually inspect both components of HyQvia for discoloration and particulate matter prior to administration.
Croatian: • Prije primjene vizualno pregledajte obje komponente lijeka HyQvia radi promjene boje i prisutnosti čestica.
English: The patient will be instructed in infusion techniques, the use of an infusion pump or syringe driver, the keeping of a treatment diary, recognition of possible severe adverse reactions and measures to be taken in case these occur.
Croatian: Bolesnika treba upoznati s tehnikama davanja infuzije, s uporabom infuzijske pumpe ili automatske štrcaljke, s vođenjem dnevnika terapije i prepoznavanjem mogućih teških nuspojava i mjera koje treba poduzeti u slučaju pojave nuspojava.
English: 5.0 (3.3 to 5.1)
Croatian: 5,0 (3,3 do 5,1)
English: First Two Infusions (ml/hour/infusion site)
Croatian: Prve dvije infuzije (ml/sat/mjesto infuzije)
English: These reactions have not been seen with HyQvia, but there is a small possibility that someone using HyQvia may get them: Blood clots in blood vessels (thromboembolic reactions) leading to heart attack, stroke, blockage of deep veins, or of blood vessels supplying the lung (pulmonary embolism), kidney disorder or failure, destruction of red blood cells (haemolysis).
Croatian: Te reakcije nisu dosad primijećene uz lijek HyQvia, ali postoji mala mogućnost da se pojave kod nekoga tko primjenjuje lijek HyQvia: Ugrušci krvi u krvnim žilama (tromboembolijski događaji), koji dovode do srčanog udara, moždanog udara, začepljenja dubokih vena ili krvnih žila koje opskrbljuju pluća (plućne embolije), poremećaj ili zatajenje bubrega, uništavanje crvenih krvnih stanica (hemoliza).
English: The following side effects have been observed with infusion of medicines like human normal immunoglobulin 10% given under the skin (subcutaneously).
Croatian: Sljedeće su nuspojave opažane s infuzijom lijekova poput normalnog ljudskog imunoglobulina 10% pod kožu (supkutano).
English: • Remove blue protective caps to expose the vial stoppers.
Croatian: • Uklonite plave zaštitne zatvarače i izložite čepove na bočicama.
English: 0.1 (0.1 to 0.1)
Croatian: 0,1 (0,1 do 0,1)
English: • patients with low antibody production prior and after transplantation of bone marrow cells from another person.
Croatian: • bolesnici s niskim stvaranjem protutijela prije i nakon transplantacije stanica koštane srži od drugih osoba
English: • Prepare to transfer the recombinant human hyaluronidase component of HyQvia by wiping each vial stopper with an alcohol swab, if directed and allow to air dry (at least 30 seconds).
Croatian: • Pripremite prijenos komponente rekombinantne ljudske hijaluronidaze lijeka HyQvia tako da svaki čep bočice prebrišete vatom natopljenom alkoholom, ako su Vas tako uputili, i pričekajte da se osuši na zraku (najmanje 30 sekundi).
English: Infusion site pain, including mild to moderate discomfort and tenderness.
Croatian: Bol mjestu primjene infuzije, uključujući blagu do umjerenu nelagodu i osjetljivost.
English: • Prepare to transfer the immunoglobulin 10% component of HyQvia by wiping each vial stopper with an alcohol swab, if directed and allow to air dry (at least 30 seconds).
Croatian: • Pripremite prijenos komponente ljudskog imunoglobulina 10% lijeka HyQvia tako da svaki čep bočice prebrišete vatom s alkoholom, ako su Vas tako uputili, i pričekate da se osuši na zraku (najmanje 30 sekundi).
English: Patients previously treated with immunoglobulin administered subcutaneously For patients currently being administered immunoglobulin subcutaneously, the initial dose of HyQvia is the same as for subcutaneous treatment, but may be adjusted to 3- or 4-weeks interval.
Croatian: Kod bolesnika kojima se trenutno imunoglobulin primjenjuje supkutano, početna mjesečna doza lijeka HyQvia ista je kao i kod liječenja supkutano, ali se može prilagoditi razmaku od 3 ili 4 tjedna.
English: 10.1 (9.5 to 10.9)
Croatian: 10,1 (9,5 do 10,9)
English: VIAL LABEL RECOMBINANT HUMAN HYALURONIDASE (2.5 ML, 5 ML, 10 ML, 15 ML)
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA NA BOČICI REKOMBINANTNE LJUDSKE HIJALURONIDAZE (2,5 ML, 5 ML, 10 ML, 15 ML)
English: A 24 gauge needle may be required to allow patients to infuse at flow rates of 300 mL/hr/infusion site.
Croatian: Igla veličine 24 G može biti potrebna kako bi bolesnici mogli primiti infuziju brzinom protoka od 300 ml na sat po mjestu primjene infuzije.
English: Items include: dual vial unit(s) of HyQvia, infusion supplies (subcutaneous needle set, solution container (bag or syringe), sterile clear bandage and tape, pump tubing, transfer devices, syringes, gauze and tape), sharps container, pump, and treatment logbook and other supplies as needed.
Croatian: Predmeti uključuju: jedinicu/e s dvostrukom bočicom lijeka HyQvia, isporučen materijal za infuziju (komplet supkutane igle, spremnik s otopinom (vrećica ili štrcaljka), sterilni prozirni flaster i ljepljivu traku, cjevčica pumpe, naprave za prijenos, štrcaljke, gaza i ljepljiva traka), spremnik za oštre predmete, pumpu, dnevnik terapije i drugi materijal po potrebi.
English: Prepare the needle set with the recombinant human hyaluronidase (HY):
Croatian: Pripremite komplet igle s rekombinantnom ljudskom hijaluronidazom (HY):
English: In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped.
Croatian: U slučaju nuspojava potrebno je smanjiti brzinu primjene ili prekinuti infuziju.
English: IG 10% is a clear or slightly opalescent and colourless or pale yellow solution.
Croatian: IG 10% je bistra ili blago opalescentna i bezbojna ili blijedožuta otopina.
English: First, the full dose of recombinant human hyaluronidase solution is infused at a rate of 1 to 2 ml/minute per infusion site or as tolerated.
Croatian: Prvo se infuzijom daje cijela doza rekombinantne ljudske hijaluronidaze, brzinom od 1 do 2 ml/minuta po mjestu primjene infuzije ili ovisno o podnošljivosti.
English: o Dispose of the sharps container using instructions provided with the container, or contact your healthcare professional.
Croatian: o Odložite spremnik za oštre predmete prema uputama dobivenima uz spremnik, ili se obratite zdravstvenom radniku.
English: o The human normal immunoglobulin 10% should be clear and colourless or pale yellow.
Croatian: ο Normalni ljudski imunoglobulin 10% mora biti bistar i bezbojan ili blijedožut.
English: Attach the pump tubing or, the larger syringe containing human normal immunoglobulin 10% to the needle set.
Croatian: Priključite cjevčicu pumpe ili veću štrcaljku koja sadrži normalni ljudski imunoglobulin 10% na komplet igle.
English: If you have an infusion site leakage
Croatian: Ako imate curenje na mjestu primjene infuzije
English: • Slowly push the plunger of the smaller syringe with the recombinant human hyaluronidase at an initial rate per infusion site to approximately 1 to 2 ml per minute and increase as tolerated.
Croatian: • Polako gurajte klip manje štrcaljke s rekombinantnom ljudskom hijaluronidazom početnom brzinom po mjestu primjene infuzije do otprilike 1 do 2 ml u minuti, a ubrzajte ako to podnosite.
English: Your doctor will calculate the correct dose for you based on your body weight, any previous treatment you may have received and your response to treatment.
Croatian: Vaše tjelesne težine, prethodnih terapija koje ste možda primili i Vašeg odgovora na terapiju.
English: If you have any questions, talk to your doctor or nurse.
Croatian: Ako imate bilo kakvih pitanja, obratite se svom liječniku ili medicinskoj sestri.
English: Discontinuation of immunoglobulin treatment may result in remission of AMS within several days without sequelae.
Croatian: Prekid imunoglobulinske terapije može imati za posljedicu remisiju sindroma aseptičkog meningitisa u roku od nekoliko dana bez posljedica.
English: Rarely human normal immunoglobulins may cause a sudden fall in blood pressure and, in isolated cases, anaphylactic shock, even when the patient has shown no hypersensitivity to previous administration.
Croatian: Rijetko, primjena normalnih ljudskih imunoglobulina može izazvati nagli pad krvnog tlaka i, u izdvojenim slučajima, anafilaktički šok, čak i kod bolesnika koji prilikom prethodnih primjena nisu pokazivali znakove preosjetljivosti.
English: Erythema, rash (including erythematous, papular, maculo-papular), pruritus, urticaria
Croatian: Poremećaji kože i supkutanog tkiva eritem, osip (uključujući eritematozni, papularni, makulo-papularni osip), pruritus, urtikarija
English: The human normal immunoglobulin 10% of HyQvia and human serum albumin (an ingredient of the recombinant human hyaluronidase) are made from human plasma (the liquid part of blood).
Croatian: Normalni ljudski imunoglobulin 10% koji HyQvia sadrži i ljudski serumski albumin (sastojak rekombinantne ljudske hijaluronidaze) dobivaju se iz ljudske plazme (tekući dio krvi).
English: Local reactions (total):
Croatian: (ukupno):
English: Cases of transient aseptic meningitis, transient hemolytic reactions, increase in serum creatinine level and/or acute renal failure have been observed with human normal immunoglobulin, see section 4.4.
Croatian: Uz primjenu normalnog ljudskog imunoglobulina opaženi su slučajevi reverzibilnog aseptičkog meningitisa, prolazne hemolitičke anemije/hemolize, porasta razine serumskog kreatinina i/ili akutnog bubrežnog zatajenja, vidjeti dio 4.4.
English: The following rare side effects have been observed in patients using medicines like human normal immunoglobulin 10% given into a vein (intravenously).
Croatian: Sljedeće su rijetke nuspojave opažane kod bolesnika koji su primjenjivali lijekove poput normalnog ljudskog imunoglobulina 10% u venu (intravenski).
English: OUTER CARTON (2.5 G, 5 G, 10 G, 20 G AND 30 G)
Croatian: (5 G, 10 G, 20 G I 30 G)
English: No long-term (chronic) changes in the skin were observed in the clinical studies.
Croatian: U kliničkim ispitivanjima nisu opažene dugotrajne (kronične) promjene kože.
English: The rHuPH20 may be hand-pushed or infused by a pump.
Croatian: Sastojak IG 10% mora se dati infuzijom uz pomoć pumpe. rHuPH20 se može potisnuti rukom ili dati infuzijom pomoću pumpe.
English: HyQvia Median (95% Cl) N=60
Croatian: HyQvia Medijan (95%-tni IP)
English: HyQvia is a dual vial unit containing: - a solution of recombinant human hyaluronidase (Step 1 of HyQvia/Infuse first) and - a solution of human normal immunoglobulin 10% (Step 2 of HyQvia/Infuse second).
Croatian: HyQvia je jedinica s dvostrukom bočicom koja sadrži: - otopinu rekombinantne ljudske hijaluronidaze (1. korak za lijek HyQvia/Infundirati prvo po redu) i - otopinu normalnog ljudskog imunoglobulina 10% (2. korak za lijek HyQvia/Infundirati drugo po redu).
English: Recombinant human hyaluronidase (rHuPH20) vial 1.25, 2.5, 5, 10 or 15 ml of solution in a vial (Type I glass) with a stopper (chlorobutyl rubber).
Croatian: Bočica s rekombinantnom ljudskom hijaluronidazom (rHuPH20) 1,25; 2,5; 5; 10 ili 15 ml otopine u bočici (staklo tipa I) s čepom (bromobutilna guma).
English: It is depolymerized by the naturally occurring enzyme hyaluronidase.
Croatian: Depolimerizira se hijaluronidazom, enzimom koji se prirodno stvara u organizmu.
English: • If instructed by your healthcare professional, attach a saline bag to the pump tubing/needle set to push the human normal immunoglobulin 10% up to the needle wings.
Croatian: • Ako Vas je tako uputio zdravstveni radnik, priključite vrećicu s fiziološkom otopinom na cjevčicu pumpe/komplet supkutane igle kako biste potisnuli normalni ljudski imunoglobulin 10% do jezičaka igle.
English: • Do not shake.
Croatian: • Nemojte protresati.
English: • Push the plunger of smaller syringe to remove the air and fill the needle set up to the needle wings with the recombinant human hyaluronidase.
Croatian: • Gurnite klip manje štrcaljke kako biste uklonili zrak i napunite komplet igle do jezičaka igle rekombinantnom ljudskom hijaluronidazom.
English: • Patients should be informed of the early signs of anaphylaxis/hypersensitivity (hives, pruritus, generalized urticaria, tightness of the chest, wheezing, and hypotension).
Croatian: • Bolesnici trebaju poznavati rane znakove anafilaksije/preosjetljivosti (koprivnjača, svrbež, generalizirana urtikarija, stezanje u prsima, piskanje u plućima i hipotenzija).
English: • Remove the cap of needle/non-vented transfer device.
Croatian: • Uklonite zatvarač s igle/neventilirane naprave za prijenos.
English: Therefore, patients receiving measles vaccine should have their antibody status checked.
Croatian: Zbog toga je kod bolesnika koji se cijepe protiv ospica potrebno provjeriti stanje protutijela.
English: Do not mix the two vials prior to administration.
Croatian: Ne miješati dvije bočice prije primjene.
English: • Allow vials to reach room temperature.
Croatian: • Prije uporabe bočice trebaju dosegnuti sobnu temperaturu.
English: • If patient is at high risk for any allergic reactions, the product should be administered only where supportive care is available for life threatening reactions.
Croatian: • Kod visoko rizičnih bolesnika po pitanju alergijskih reakcija lijek se smije primjenjivati samo kada je dostupna suportivna njega u slučaju po život opasne reakcije.
English: The dosage interval to maintain steady state levels varies from 2-4 weeks.
Croatian: Za održavanje postignutog stanja dinamičke ravnoteže razmak između doziranja varira između 2 i 4 tjedna.
English: AMS may occur more frequently in association with high-dose (2 g/kg) intravenous immunoglobulin treatment.
Croatian: Sindrom aseptičkog meningitisa se javlja učestalije kod viših doza (2 g/kg) intravenske imunoglobulinske terapije.
English: HyQvia is a dual vial unit consisting of one vial of human normal immunoglobulin (Immune Globulin 10% or IG 10%) and one vial of recombinant human hyaluronidase (rHuPH20).
Croatian: HyQvia je jedinica s dvostrukom bočicom koja se sastoji od jedne bočice normalnog ljudskog imunoglobulina (imunoglobulin 10% ili IG 10%) i jedne bočice rekombinantne ljudske hijaluronidaze (rHuPH20).
English: • Do not heat up or shake HyQvia.
Croatian: • Nemojte zagrijavati ili mućkati lijek HyQvia.
English: Local reactions at infusion sites: swelling, soreness, redness, induration, local heat, itching, bruising and rash, may frequently occur.
Croatian: Lokalne reakcije na mjestima primjene infuzije: često se mogu pojaviti oticanje, osjetljivost, crvenilo, induracija, lokalni osjećaj topline, svrbež, modrice i osip.